InterVein-D2L Pharma to jointly provide clinical research solutions

Ahmedabad, Jan 22 (UNI) City-based InterVein Laboratories and D2L Pharma Research Solutions have signed a Memorandum of Understanding (MoU) for providing one stop solutions to the clinical research industry.

InterVein is a central laboratory commenced its operations in 2006 and has a focused business model of catering to clinical trial samples only. It is one of the few central laboratories in the country providing such services to clinical research.

D2L Pharma Research Solutions is engaged in site management and consulting services. D2L-SMO, one of the divisions of D2L Pharma Research Solutions, has agreed to collaborate with InterVein for providing their services in clinical investigations and site management services. This partnership will enable them to jointly provide a fully integrated platform to pharmaceutical companies and CROs from site management solutions for clinical lab testing.

''The collaboration will bring in one stop solutions to the clients looking for a central lab with focus on clinical trials networked with trial sites with speedy and efficient sample collection system and handling of logistics,'' InterVein Laboratories CEO Devina Bhardwaj said.

UNI HT NM SM1633